
In collaboration with a number of research units and companies, the Danish cancer biologist Kristian Helin now has to use his many years of experience to crack the code and discover the intricate and crucial answers concerning embryonic stem cells.
The new EU-project, 4DCellFate, focuses on an understanding of why the growth of stem cells is regulated. Eight academic institutions, three biotech companies and one pharmaceutical company join hands to share knowledge and create results backed by 12 million Euros in EU-funds.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app